These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 35994940

  • 1. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM, Croxford S, Viviani L, Emanuel E, Phipps E, Desai M.
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [Abstract] [Full Text] [Related]

  • 2. The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland.
    Trickey A, Croxford S, Emanuel E, Ijaz S, Hickman M, Kesten J, Thomas C, Edmundson C, Desai M, Vickerman P.
    Clin Infect Dis; 2022 Sep 29; 75(6):1073-1077. PubMed ID: 35184173
    [Abstract] [Full Text] [Related]

  • 3. Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.
    Trickey A, May MT, Hope V, Ward Z, Desai M, Heinsbroek E, Hickman M, Vickerman P.
    Drug Alcohol Depend; 2018 Nov 01; 192():118-124. PubMed ID: 30245460
    [Abstract] [Full Text] [Related]

  • 4. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, Ncube F.
    Int J Drug Policy; 2017 Aug 01; 46():34-40. PubMed ID: 28586701
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey.
    Cullen KJ, Hope VD, Croxford S, Shute J, Ncube F, Parry JV.
    Epidemiol Infect; 2015 May 01; 143(7):1398-407. PubMed ID: 25119383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California.
    Ozga JE, Syvertsen JL, Pollini RA.
    J Viral Hepat; 2022 Jul 01; 29(7):518-528. PubMed ID: 35357738
    [Abstract] [Full Text] [Related]

  • 11. A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.
    Hope VD, Harris RJ, Vickerman P, Platt L, Shute J, Cullen KJ, Ijaz S, Mandal S, Ncube F, Desai M, Parry JV.
    Euro Surveill; 2018 Nov 01; 23(47):. PubMed ID: 30482265
    [Abstract] [Full Text] [Related]

  • 12. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P, Guarino H, Zibbell JE, Teubl J, Fong C, Goodbody E, Edlin B, Salvati C, Friedman SR.
    Harm Reduct J; 2020 Mar 30; 17(1):22. PubMed ID: 32228700
    [Abstract] [Full Text] [Related]

  • 13. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
    Trickey A, Semchuk N, Saliuk T, Sazonova Y, Varetska O, Walker JG, Lim AG, Stone J, Vickerman P.
    J Int AIDS Soc; 2020 Aug 30; 23(8):e25608. PubMed ID: 32851812
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
    McFall AM, Solomon SS, Lucas GM, Celentano DD, Srikrishnan AK, Kumar MS, Mehta SH.
    Addiction; 2017 Aug 30; 112(8):1480-1487. PubMed ID: 28317210
    [Abstract] [Full Text] [Related]

  • 19. The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.
    Bardsley M, Heinsbroek E, Harris R, Croxford S, Edmundson C, Hope V, Hassan N, Ijaz S, Mandal S, Shute J, Hutchinson SJ, Hickman M, Sinka K, Phipps E.
    J Viral Hepat; 2021 Oct 30; 28(10):1452-1463. PubMed ID: 34270172
    [Abstract] [Full Text] [Related]

  • 20. Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?
    Gliddon HD, Ward Z, Heinsbroek E, Croxford S, Edmundson C, Hope VD, Simmons R, Mitchell H, Hickman M, Vickerman P, Stone J.
    Int J Drug Policy; 2024 Jan 12; ():104324. PubMed ID: 38218700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.